La teoría del Big Bang es uno de los conceptos más fascinantes y revolucionarios en el campo de la cosmología. Nos ofrece una explicación sobre el origen y evolución del universo tal como lo conocemos. En este artículo, desglosaremos de manera sencilla la te …
El Big Bang: El nacimiento del universo en un instante cósmico Read More »
Los virus han sido objeto de estudio y preocupación durante siglos debido a su capacidad de causar enfermedades en humanos, animales y plantas. Sin embargo, ¿alguna vez te has preguntado qué pasaría si los virus desaparecieran por completo? En este artículo, examin …
El mundo sin virus: Un escenario fascinante y desafiante Read More »
El vuelo espacial ha sido una de las mayores hazañas científicas y tecnológicas de la humanidad, y gran parte de su éxito se debe al desarrollo de cohetes propulsores. Pero, ¿alguna vez te has preguntado cuál fue el primer cohete que logró volar impul …
El vuelo revolucionario: El primer cohete de combustible líquido en la historia Read More »
GC Genome Corporation, a leading genomic diagnostics company, announced the publication of a study in Frontiers in Microbiomes.
GC Genome’s New Study Reveals Link Between Gut Microbiome and High Blood Pressure Read More »
OSE Immunotherapeutics SA presents scientific updates in oral and poster presentations selected for international conferences: at the Antibody Engineering & Therapeutics Europe 2023 Conference in Amsterdam, Netherlands, at the FOCIS 2023 Annual Meeting, the 4th Annual Cytokine-Based Drug Development Summit 2023 and at the 3rd Annual Tumor Myeloid-directed Therapies Summit 2023 in Boston, US.
With immunotherapy emerging as one of the most important treatment options in oncology, GE HealthCare has announced the first patient scanned in a Phase I clinical trial of a first-of-its kind fluorine-18 PET radiopharmaceutical specific for CD8, which is expressed on CD8+ T cells – a subpopulation of white blood cells which fight cancer.
Metagen Therapeutics, a company focusing on drug discovery and development based on intestinal microbiome-based therapeutics for various diseases, has completed its Series A funding in 2 rounds, raising a total of 1.7 billion yen.
Metagen Therapeutics Completes Series A Financing Raising a Total of 1.7 Billion Yen Read More »
Editas Medicine, Inc., a clinical-stage genome editing company, announced the pricing of an underwritten offering of 12,500,000 shares of its common stock at a public offering price of $10.00 per share, before deducting underwriter discounts and commissions and estimated offering expenses.
Editas Medicine Announces Pricing of Offering of Common Stock – June 15, 2023 Read More »
The Annual General Shareholder Meeting of Pixium Vision SA, a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, met in Paris on June 13, 2023, and adopted all the resolutions put to the vote.
Results of the Annual General Shareholder Meeting as of June 13, 2023 Read More »
Bone Biologics Corporation, a developer of orthobiologic products for spine fusion markets, announced the pricing of an underwritten public offering of common stock.
Bone Biologics Prices $5.0 Million Underwritten Public Offering Read More »
